Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ANADYS PHARMACEUTICALS INC | a55326e10vk.htm |
| EX-31.1 - EX-31.1 - ANADYS PHARMACEUTICALS INC | a55326exv31w1.htm |
| EX-32.1 - EX-32.1 - ANADYS PHARMACEUTICALS INC | a55326exv32w1.htm |
| EX-31.2 - EX-31.2 - ANADYS PHARMACEUTICALS INC | a55326exv31w2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (No.’s
333-113954, 333-120647, 333-129716, 333-137114, 333-145889, 333-154743 and 333-162776) and Form S-3
(No.’s 333-124231, 333-132729 and 333-158342) of Anadys Pharmaceuticals, Inc. and in the related
Prospectus, of our reports dated March 1, 2010, with respect to the consolidated financial
statements of Anadys Pharmaceuticals, Inc., and the effectiveness of internal control over
financial reporting of Anadys Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for
the year ended December 31, 2009.
/s/ Ernst & Young LLP
San Diego, California
March 1, 2010
March 1, 2010